{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:07:02Z","timestamp":1785852422889,"version":"3.56.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    We report\n                    <jats:sup>18<\/jats:sup>\n                    F-AV1451 PET\/MRI findings of a 56-year-old man with progressive supranuclear palsy (PSP). The images revealed multifocal\n                    <jats:sup>18<\/jats:sup>\n                    F-AV1451 tracer uptake in both intracranial and extracranial regions, with increased retention in bilateral basal ganglia regions and scalp soft tissue. The findings may reflect systemic tau pathology and provide the clinical experience for the possible assessment of the disease severity.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006251","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:00:27Z","timestamp":1766502027000},"page":"e650-e651","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Increased 18F-AV1451 Retention in Soft Tissue of Patients With Progressive Supranuclear Palsy"],"prefix":"10.1097","volume":"51","author":[{"given":"Lixiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-6668","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00415-025-12994-5","article-title":"Overlapping presence of \u03b2-amyloid, tau, p-tau, and \u03b1-synuclein in skin nerve fibers in Alzheimer\u2019s disease","volume":"272","author":"Buchholz","year":"2025","journal-title":"J Neurol"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-181191","article-title":"Neurodegenerative disease-related proteins within the epidermal layer of the human skin","volume":"69","author":"Akerman","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41531-024-00728-9","article-title":"Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies","volume":"10","author":"Dellarole","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","article-title":"Overview of tau PET molecular imaging","volume":"35","author":"Cassinelli Petersen","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13024-024-00781-1","article-title":"Seeding activity of skin misfolded tau as a biomarker for tauopathies","volume":"19","author":"Wang","year":"2024","journal-title":"Mol Neurodegener"},{"key":"R6-20260702","first-page":"s6","article-title":"Presence of phosphorylated tau protein in the skin of Alzheimer\u00b4s disease patients","volume":"s6","author":"Guadalupe","year":"2015","journal-title":"J Mole Biomarkers Diagnosis"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12149-017-1205-0","article-title":"Uptake of AV-1451 in meningiomas","volume":"31","author":"Bruinsma","year":"2017","journal-title":"Ann Nucl Med"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marqui\u00e9","year":"2015","journal-title":"Ann Neurol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:43:04Z","timestamp":1785850984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006251","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"2025-09-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}